The U.S. Government Is Investing $2 Billion in the Quantum Computing Space, But Did It Miss the Best Stock to Buy?

The U.S. government plans to deploy over $2 billion in incentives and equity investments for nine quantum computing companies under the CHIPS and Science Act, including $1 billion each for IBM's Anderon and $375 million for GlobalFoundries. Seven other names, including Rigetti, D-Wave Quantum, and Infleqtion, are also slated for equity support, while IonQ was notably excluded despite its strong technical lead and SkyWater acquisition. The news is supportive for the quantum computing sector overall, though the market may view IonQ's omission as a relative missed opportunity.

Analysis

This is less a broad quantum-positive event than a selective industrial-policy signal: Washington is effectively underwriting the buildout of domestic quantum capacity, which should compress funding risk for the chosen names and increase the value of “made-in-USA” supply chains. The second-order winner is not just the firms receiving checks, but the adjacent equipment, packaging, substrate, and cleanroom ecosystem that becomes a quasi-captive procurement base over the next 12-24 months. That said, government capital is also a validation filter — firms outside the program may face a higher cost of capital if the market interprets the list as a de facto ranking.

The market’s likely mistake is conflating policy inclusion with technology leadership. If IonQ’s integration roadmap and accuracy advantage are real, then omission from this tranche may be a better signal than inclusion: it suggests the government is optimizing for domestic manufacturing jobs and controllable industrial footprint, not necessarily the highest-performing architecture. That creates a potential mispricing in the near term, because the winners of subsidy flow can outperform on sentiment while the winner of technical credibility may compound over a longer horizon once error-correction milestones become the gating factor.

The key risk is timeline mismatch. Subsidy headlines can move stocks for days to weeks, but commercial quantum revenue inflection is still a years-long story; any slip in foundry execution, equity-dilution optics, or disappointment around milestone-based disbursements could quickly unwind the move. For IonQ specifically, the contrarian setup is that the stock may lag on headline optics now but outperform later if vertical integration reduces manufacturing bottlenecks and preserves technical leadership. The market should treat this as a relative-value event, not a clean directional long on the sector.

Key Decisions for Investors

• Long IONQ vs short QBTS in a 3-6 month pair trade: bet that technical leadership and vertical integration matter more than subsidy participation, with upside if the market rerates IonQ as the eventual category leader.
• Take tactical longs in IBM and GFS for 1-4 weeks into the next policy/newsflow window: these are the cleanest beneficiaries of government validation, but trim aggressively on any 10-15% squeeze as the move is more sentiment-driven than near-term earnings-driven.
• Buy SKYT on pullbacks and hold 6-12 months: the acquisition angle creates strategic scarcity value, but size modestly because integration and regulatory timing can delay the thesis.
• Avoid chasing QBTS on the headline alone; if entering, use call spreads rather than stock to cap downside, since policy support improves runway but does not eliminate execution risk.
• For a cleaner risk/reward expression, consider a basket long of IBM/GFS against a small short in a quantum laggard basket, with a stop if the sector re-rates on a broader federal funding wave beyond the named companies.